Results 141 to 150 of about 6,796 (211)

HG-67PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPG [PDF]

Neuro-Oncology, 2016
Diana Carvalho, Kathryn Taylor, Nagore G. Olaciregui, Melanie Valenti, Ruth Ruddle, Alan Henley, Angela Hayes, Alexis De Haven Brandon, Albert Hallsworth, Alan Mackay, Valeria Molinari, Maria Vinci, Sergey Popov, Aicha Boudhar, Paul Brennan, Andrew Moore, Liam Hudson, Swen Hoelder, Alex Bullock, Florence Raynaud, Sue Eccles, Angel M. Carcaboso, Chris Jones   +22 more
openaire   +1 more source

Primary Cilia Are Required for Efficient BMP Signaling in Traumatic Heterotopic Ossification. [PDF]

Biomedicines
Yuan X, Toutounchi S, Law SF, Achudhan D, Chandra A, He K, Cao Y, Hu J, Pignolo RJ, Wang H.   +9 more
europepmc   +1 more source

Effects of miR-128-3p on Renal Inflammation in a Rat Periodontitis Model. [PDF]

Dent J (Basel)
Nurhamim M, Zhang Y, Nakahara M, Fukuhara D, Nagashima Y, Maruyama T, Morita M, Ekuni D.   +7 more
europepmc   +1 more source

Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth. [PDF]

Ann Surg Oncol
Kato S, Miyoshi N, Fujino S, Horie M, Yachida S, Takeda M, Sekido Y, Hata T, Hamabe A, Ogino T, Uemura M, Yamamoto H, Yasui M, Ohue M, Doki Y, Eguchi H.   +15 more
europepmc   +1 more source

Theoretical-Experimental Analysis to Elucidate the Mechanism of Action of Novel Anabolic Agents. [PDF]

Molecules
Quiroga I, Cardenas-Garcia M, Hernández-Linares MG, Guerrero-Luna G, Flores-Manuel F.   +4 more
europepmc   +1 more source

PDTB-20. PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPG [PDF]

Neuro-Oncology, 2016
Diana Carvalho, Kathryn Taylor, Nagore Gene Olaciregui, Melanie Valenti, Ruth Ruddle, Alan Henley, Angela Hayes, Alexis De Haven Brandon, Alan MacKay, Valeria Molinari, Maria Vinci, Sergey Popov, Paul Brennan, Andrew Moore, Liam Hudson, Swen Hoelder, Alex Bullock, Florence Raynaud, Sue Eccles, Angela Montero Carcaboso, Chris Jones   +20 more
openaire   +1 more source

A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice. [PDF]

Bone
Yang J, Pan H, Sekimata K, Hwang C, Kulkarni A, Thomas H, Lindenau J, Duford T, Ueharu H, Tanaka A, Sakai N, Shirouzu M, Hashizume Y, Levi B, Koyama H, Mishina Y.   +15 more
europepmc   +1 more source

Intermittent and Short-Term Empirical Ruxolitinib Regimen for Steroid-Refractory Flareups of Fibrodysplasia Ossificans Progressiva. [PDF]

Pharmacol Res Perspect
Chen RL, Yang TH, Wang YH, Shaw JJ, Chen LY.   +4 more
europepmc   +1 more source

Fibrodysplasia Ossificans Progressiva: A Case Report From the UAE. [PDF]

Cureus
Al Karam TM, Alkaram BM, Basil RZ, Alzaghal SA, Ahmed A.   +4 more
europepmc   +1 more source

Inhibition of astrocyte BMP signaling alleviates neuroinflammation in experimental models of Parkinson's disease. [PDF]

Cell Death Discov
Li Y, Li Y, Hao J, Wang W, Su Z, Tian X, Wang H, Liu Q, Gao J, Geng D, Wang L.   +10 more
europepmc   +1 more source